NuVasive, a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, has appointed Michael Lambert as executive vice president (EVP) and chief financial officer (CFO).
Lambert has been CFO and held other key financial positions at other public companies. Most recently, he was the CFO of Advanced Medical Optics, a medical device company focused on technologies used by eye care professionals. As the financial leader of a global organisation, he developed in-depth operational expertise and critical analytical skills.
Lambert will succeed Kevin O’Boyle, who has served as CFO since the company went public in 2004. O’Boyle will actively assist Lambert’s transition into his new role through the end of the year.
A report by broking group Marsh examines the repercussions from the administration of the South Korean company, which filed for bankruptcy protection at the end of August.
Global research by C2FO suggests that smaller businesses are less concerned with the repercussions of Brexit and the upcoming US presidential election.
A squeeze on skilled talent means it now takes an average of seven weeks to fill open permanent roles in finance in the UK according to new research from financial services recruitment firm Robert Half.
Early-stage merger and acquisition deals in Asia-Pacific show nearly 10% year-on-year growth in recent months.